Caesars Entertainment's analyst coverage has been reshaped by the pending transaction. Since the buyout was announced in May 2026, price targets from firms including Barclays, Stifel, J.P. Morgan, Susquehanna, Wells Fargo, and TD Cowen have converged on $31 — the cash offer — accompanied by a wave of downgrades to Hold or Neutral. The consensus rating across more than a dozen covering analysts is Hold, and the average price target is approximately $31, according to data compiled by MarketWatch, Barron's, and TipRanks. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Before the deal, targets were scattered: some firms carried $26 figures, while Morgan Stanley had a $34 target and Citizens JMP a $35 target. Those pre-merger levels are now largely moot. In other words, the $31 "target" is not a forecast of fundamental value but a reflection of the agreed merger consideration.
The stock closed near $29.06, putting the $31 objective roughly 6.7% higher — a modest gap. It has traded as high as $30.88 over the past 52 weeks, just beneath the offer price, after recovering from a 52-week low of $17.86. The path to $31 runs almost entirely through the regulatory process rather than operations. Caesars shareholders approved the merger with 65.4% of outstanding shares voting in favor on September 22, 2026. The remaining obstacle is the FTC, which issued a second request for information on September 14, 2026, extending the Hart-Scott-Rodino waiting period. The company reported third-quarter revenue of about $2.94 billion and a GAAP net loss of $123 million, and it remains unprofitable on a GAAP basis — but those fundamentals matter less than whether the deal closes.
The 52-week high of $30.88 sits just under the $31 offer, effectively capping the stock while the deal is pending. The shares have consolidated in the high $20s during the regulatory review, with the $29 area serving as a near-term reference and $31 acting as a hard ceiling tied to the cash consideration.
Analyst price targets ordinarily reflect a 12-month research horizon, but here the relevant clock is the merger timeline. Key items to watch include the FTC's review and any compliance milestones under the second request, the 30-day post-compliance waiting period, and any required divestitures. The merger agreement includes a ticking fee of $0.007150 per share per day if closing slips beyond June 26, 2027. Caesars' next earnings release and any update on deal financing or renegotiation also remain important. From what I see, monitoring these regulatory steps is central to assessing the position.
Tickeron's AI Daily Buy/Sell Signals have become a regular part of my process for situations like this. The platform applies artificial intelligence to scan thousands of stocks and ETFs, delivering Buy, Sell, or Hold signals based on technical behavior and market shifts. In a merger-arbitrage setup such as Caesars, these signals help cut through noise and keep track of broader sector trends without constant manual checks. I find the approach useful for confirming timing around regulatory updates or position adjustments.
Caesars Entertainment (CZR) is less a fundamental-upside story than a merger-arbitrage situation. The $31 central target is the all-cash acquisition price, and the stock's roughly 6.7% discount to it reflects the market's assessment that the deal may be delayed or, less likely, not close. The strongest supports are completed shareholder approval and the fixed cash consideration; the principal obstacles are the FTC's extended review and the company's high leverage. What matters next is not earnings growth but the regulatory path and any closing conditions. Investors should weigh the modest remaining premium against the risk that the transaction is modified or abandoned.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The RSI Indicator for CZR moved out of oversold territory on October 29, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 37 similar instances when the indicator left oversold territory. In 31 of the 37 cases the stock moved higher. This puts the odds of a move higher at 84%.
The Moving Average Convergence Divergence (MACD) for CZR just turned positive on November 02, 2026. Looking at past instances where CZR's MACD turned positive, the stock continued to rise in 38 of 52 cases over the following month. The odds of a continued upward trend are 73%.
Following a +0.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where CZR advanced for three days, in 196 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
CZR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 62 cases where CZR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 76%.
The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CZR as a result. In 73 of 105 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CZR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
The Aroon Indicator for CZR entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.765) is normal, around the industry mean (14.575). P/E Ratio (-12.877) is within average values for comparable stocks, (53.870). CZR's Projected Growth (PEG Ratio) (4.468) is very high in comparison to the industry average of (0.784). Dividend Yield (0.000) settles around the average of (0.022) among similar stocks. P/S Ratio (0.522) is also within normal values, averaging (1.049).
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. CZR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CZR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an operator of hotels and casinos
Industry HotelsResortsCruiselines